Fig. 1From: Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)Study design. PFT Pulmonary Function Test, CT Computed Tomography, MRI Magnetic Resonance Imaging, PBS Peripheral Blood Sample, TITE-CRM time-to-event continual reassessment methodBack to article page